DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

02877 SHINEWAY PHARM

Closed Add to Porfolio
Index Constituent : HS Composite Index, HS Comp. M & S Index, HS Comp.SmallCap Ind, Stock Connect HK Ind, Stock Connect HK MS, Stock Connect HK S I
Major Shareholders LI Zhenjiang (66.12%) Sector Health Care & Biotechnology
Web Site http://www.shineway.com.hk Tel (852) 3521-0816
Email randyhung@shineway.com.hk Fax N/A
Related Equities N/A
Principal Activities The principal activities are research and development, manufacturing and trading of modern Chinese medicines.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Hill David Henry Christopher 546,802,990(L)  66.12(L)  14/12/2017
Hill Rebecca Ann 546,802,990(L)  66.12(L)  14/12/2017
李振江 546,802,990(L)  66.12(L)  14/12/2017
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
徐勝 2,000,000(L)  0.24(L)  17/12/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top